SecBot SecBot

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

H.R. 6094 Rep. Doris Matsui (D-CA-7) In committee
Bill text PDF
  1. Introduced Oct 26
  2. Committee Oct 26
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Oct 26, 2023Next: House vote
680d ago Dec 17, 2024: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 2 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 2
Search all 2 companies, their asks and price moves Subscribe

Summary

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act

Full summary1 paragraphs

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

Library of Congress summary, Oct 26, 2023

Summary versions
  • Introduced in HouseOct 26, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.